DICE - DICE Therapeutics reports Q3 results
DICE Therapeutics (NASDAQ:DICE): Q3 GAAP EPS of -$2.30. Cash and cash equivalents and marketable securities totaled $335.7M Press Release
For further details see:
DICE Therapeutics reports Q3 resultsLink your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
| Company Name: | DICE Therapeutics Inc. |
| Stock Symbol: | DICE |
| Market: | NASDAQ |
| Website: | dicetherapeutics.com |
Get DICE Alerts
News, Short Squeeze, Breakout and More Instantly...